Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

BioMarin Pharmaceutical Company Profile (NASDAQ:BMRN)

Consensus Ratings for BioMarin Pharmaceutical (NASDAQ:BMRN) (?)
Ratings Breakdown: 5 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.62)
Consensus Price Target: $89.50 (0.25% downside)

Current Analysts' Coverage Summary for BioMarin Pharmaceutical (NASDAQ:BMRN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/25/2014Jefferies GroupBoost Price TargetBuy$87.00 -> $100.00ViewTweet This Rating  Share This Rating on StockTwits
11/25/2014RBC CapitalBoost Price TargetOutperform$87.00 -> $103.00ViewTweet This Rating  Share This Rating on StockTwits
11/24/2014NomuraUpgradeNeutral -> BuyViewTweet This Rating  Share This Rating on StockTwits
11/10/2014Goldman SachsUpgradeNeutral -> Buy$78.00 -> $104.00ViewTweet This Rating  Share This Rating on StockTwits
11/3/2014Wells Fargo & Co.UpgradeMarket Perform -> OutperformViewTweet This Rating  Share This Rating on StockTwits
10/27/2014ZacksReiterated RatingNeutral -> Neutral$85.00ViewTweet This Rating  Share This Rating on StockTwits
10/27/2014Credit SuisseReiterated RatingOutperform$74.00 -> $75.00ViewTweet This Rating  Share This Rating on StockTwits
10/27/2014WedbushReiterated RatingNeutral$76.00 -> $77.00ViewTweet This Rating  Share This Rating on StockTwits
10/16/2014SunTrustInitiated CoverageBuy$100.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
2/19/2014BarclaysBoost Price TargetEqual Weight$73.00 -> $76.00ViewTweet This Rating  Share This Rating on StockTwits
2/19/2014Citigroup Inc.Boost Price Target$79.00 -> $90.00ViewTweet This Rating  Share This Rating on StockTwits
1/14/2014Deutsche BankBoost Price TargetBuy$75.00 -> $85.00ViewTweet This Rating  Share This Rating on StockTwits
11/29/2013TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
11/26/2013Piper JaffrayInitiated CoverageOverweight$87.00ViewTweet This Rating  Share This Rating on StockTwits
9/18/2013William BlairReiterated RatingHold$88.00ViewTweet This Rating  Share This Rating on StockTwits
9/18/2013Stifel NicolausDowngradeBuy -> Hold$70.00ViewTweet This Rating  Share This Rating on StockTwits
9/16/2013Bank of AmericaReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
9/5/2013Canaccord GenuitySet Price TargetBuy$71.00 -> $85.00ViewTweet This Rating  Share This Rating on StockTwits
6/3/2013Leerink SwannReiterated RatingOutperform -> PositiveViewTweet This Rating  Share This Rating on StockTwits
4/18/2013Lazard LtdBoost Price TargetBuy$71.00 -> $77.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2013S&P Equity ResearchDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Janney Montgomery ScottInitiated CoverageBuy$60.00ViewTweet This Rating  Share This Rating on StockTwits
1/2/2013JPMorgan Chase & Co.Reiterated RatingOverweight$60.00ViewTweet This Rating  Share This Rating on StockTwits
12/4/2012Robert W. BairdReiterated RatingOutperform$54.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/29/2012 forward)